Bladder Filling Variation in Cancer Cervix Patients Treated by Image Guided Radiation Therapy
- Authors
-
-
Anshuma Bansal
Department of Radiation Oncology, Government Medical College, Rajindra Hospital, Patiala, India -
Gandharv Vyas
Department of Radiation Oncology, Government Medical College, Rajindra Hospital, Patiala, India -
Neeru Bedi
Department of Radiation Oncology, Government Medical College, Rajindra Hospital, Patiala, India -
Aditya Singla
Department of Radiation Oncology, Government Medical College, Rajindra Hospital, Patiala, India -
Sunigdha Charry
Department of Radiation Oncology, Government Medical College, Rajindra Hospital, Patiala, India -
Gurpreet Singh
Department of Radiation Oncology, Government Medical College, Rajindra Hospital, Patiala, India -
Vinod Kumar Dangwal
Department of Radiation Oncology, Government Medical College, Rajindra Hospital, Patiala, India -
Raja Paramjeet Singh
Department of Radiation Oncology, Government Medical College, Rajindra Hospital, Patiala, India
-
- Keywords:
- Cervix cancer, Bladder filling, Cone Beam CT, Image Guided Radiation Therapy
- Abstract
-
Variable bladder filling during radiotherapy for carcinoma cervix significantly affects the position of target volumes to be treated. This directly impacts the precision with which advanced radiotherapy plans are delivered using specific margins to target volumes. The aim is to study mean bladder volumes and mean range of bladder motion in all three dimensions in patients of carcinoma cervix treated with Image guided radiation therapy (IGRT), and compare them to the baseline planning Computed tomography (CT) scans. For this, a total number of 25 patients/ 150 CT scans, i.e. 25 planning scan and 125 CBCT (cone-beam CT) were analyzed. The bladder volumes and bladder wall dimension were analyzed using offline views of CBCT imaging, conducted weekly for cervix cancer patients, thus adding considerable understanding to the bladder wall motions. The mean bladder volume for all 25 patients was 263.41 cc with standard deviation of 110.174 cc. When mean CBCT bladder volumes of each patient were compared to their respective planning CT bladder volumes, P was found to be insignificant (p=0.25), showing consistent bladder filling or reproducibility during treatment. The mean ± standard deviation of bladder’s transverse, anteroposterior and supero-inferior dimension was 9.55 ± 0.923 cm; 6.92 ± 2.387 cm and 7.22 ± 0.967 cm. The mean supero-inferior bladder diameter had significant variation from that of the planning CT (7.84 ± 2.749 cm vs 6.92 ± 2.387) with p = 0.018. This study shows that more liberal margins should be considered in supero-inferior dimensions and considerable lesser margins could be given on the lateral sides, as there is less displacement in transverse diameter.
- References
-
[1] Ahmad R, Hoogeman MS, Quint S, Mens JW, de Pree I, Heijmen BJ. Inter-fraction bladder filling variations and time trends for cervical cancer patients assessed with a portable 3-dimensional ultrasound bladder scanner. Radiother Oncol 2008; 89: 172-9.
[2] Pos FJ, Koedooder K, Hulshof MC, van Tienhoven G, González González D. Influence of bladder and rectal volume on spatial variability of a bladder tumor during radical radiotherapy. Int J Radiat Oncol Biol Phys 2003; 55: 835-41.
[3] Lim K, Small Jr W, Portelance L, Creutzberg C, Jürgenliemk-Schulz IM, Mundt A, Mell LK, et al. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy for the definitive treatment of cervix cancer. Inter J Rad Onc Bio Phy 2011; 79(2): 348-55.
[4] IBM Corp. IBM SPSS Statistics for Windows, Version 26.0. Armonk, NY: IBM Corp 2019.
[5] Liu H, Zhang Z, Guo X, Wang T, Hu J, Shao J, Chi F, He H. The Effect of Bladder and Rectum Volume Changes on Exposed Organ Volume During Intensity-Modulated Radiotherapy for Cervical Cancer. Clinical Medicine Insights: Oncology 2025; 19: 11795549251377910.
[6] Yee D, Parliament M, Rathee S, Ghosh S, Ko L, Murray B. Cone beam CT imaging analysis of interfractional variations in bladder volume and position during radiotherapy for bladder cancer. Int J Radiat Oncol Biol Phys 2010; 76: 1045-53.
[7] Nishioka K, Shimizu S, Kinoshita R, Inoue T, Onodera S, Yasuda K, et al. Evaluation of inter-observer variability of bladder boundary delineation on cone-beam CT. Radiat Oncol 2013; 8: 185.
[8] Jhingran A, Salehpour M, Sam M, Levy L, Eifel PJ. Vaginal motion and bladder and rectal volumes during pelvic intensity-modulated radiation therapy after hysterectomy. Int J Radiat Oncol Biol Phys 2012; 82: 256-62.
[9] Wang J, Li T, Xing L. Low-dose CBCT imaging for external beam radiotherapy. Int J Radiat Oncol Biol Phys 2008; 72: S109-10.
[10] Fokdal L, Honoré H, Høyer M, Meldgaard P, Fode K, von der Maase H.Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer. Int J Radiat Oncol Biol Phys 2004; 59: 436-44.
[11] Shah M, Agarwal S, Agarwal R, Subramanian B, Gupta S, De S, Mishra S. Observational study of cone beam computed tomography based interfractional urinary bladder filling variation during image guided radiation therapy in pelvic malignancies. Journal of Cancer Research and Therapeutics 2021; 17(1): 152-6.
[12] Nanda DS, Meher DP, Mishra DS, Parihar DA, Dhakar DM. Observational Study Based on Interfractional Urinary Bladder Filling Variations during Image Guided Radiotherapy in Cervical Cancer Patients Using Cone Beam Computed Tomography. International Journal of Radiation Oncology, Biology, Physics 2024; 120(2): e92.
[13] Zhang F, Zhou M, Wang G, Li X, Yue L, Deng L et al. Evaluation of bladder filling effects on the dose distribution during radiotherapy for cervical cancer based on daily CT images. Journal of Applied Clinical Medical Physics 2023; 24(11): e14097.
[14] Wang H, Li Z, Shi D, Yin P, Liang B, Zou J et al. Assessing intra-and interfraction motion and its dosimetric impacts on cervical cancer adaptive radiotherapy based on 1.5 T MR-Linac. Radiation Oncology 2024; 19(1): 176.
[15] Koca T, AKSOY R, Atak E, Kizilkaya M, BİLEK Y, Tunçel N et al. Evaluation of the Dosimetric Effects of Bladder and Rectum Filling in Patients with Gynecologic Cancer Receiving Adjuvant Radiotherapy. Turk Onkoloji Dergisi 2025; 40(1).
[16] Nair SR, Gupta S, Krishnan AS, Chophy A, Rastogi A, Kumar RR, Namitha RS, Joseph DM, Gupta M. Volumetric and Dosimetric Changes in Bladder and Rectum and Target During Intensity-Modulated Radiotherapy in Patients of Locally Advanced Carcinoma Cervix. Indian Journal of Gynecologic Oncology 2025; 23(1): 31.
[17] Fischer J, Fischer LA, Bensberg J, Bojko N, Bouabdallaoui M, Frohn J, Hüttenrauch P, Klingebiel M, Schmitt D, Tegeler K, Wagner D. CBCT-based online adaptive radiotherapy of the bladder–geometrical and dosimetrical considerations compared to conventional IGRT. Radiation Oncology 2025; 20(1): 128.
- Downloads
- Published
- 2025-10-29
- Issue
- Vol. 14 (2025)
- Section
- Articles
- License
-

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Similar Articles
- Kenji Ina, Ryuichi Furuta, Takae Kataoka, Sayaka Sugiura, Satoshi Kayukawa, Takayuki Kanamori, Takaki Kikuchi, Megumi Kabeya, Satoshi Hibi , Shu Yuasa , Adverse Effects of Bevacizumab During Treatment for Metastatic Colorectal Cancer , Journal of Analytical Oncology: Vol. 4 No. 1 (2015)
- Pedro Salinas Hernández, Rafael Trujillo Vilchez, Antonio Arriví García-Ramos, Rosana Grande Ladron de Guevara, Angeles Rodríguez Jaraiz, Pedro Gallurt Moreira, Jose Maria Vieitez de Prado, Miguel Ruiz López de Tejada, Antonio Irigoyen Medina, Juan Manuel Campos Cervera, Juan Carlos Cámara Vicario, Uriel Bohn Sarmiento, Pedro López Tendero, Juan Domingo Alonso Lajara, Ana León Carbonero, Marisa García de Paredes, Juan de Alvaro Liaño, Asunción Juarez Marroquí, Luis López Gómez , Diego Soto de Prado Otero, Bevacizumab Plus Chemotherapy as First-Line Treatment for Patients with Metastatic Colorectal Cancer: Results from a Spanish Observational Study , Journal of Analytical Oncology: Vol. 2 No. 3 (2013)
- Krystal A. Hughes, Gerald M. Higa, Molecular Pathology of Immune Checkpoint Inhibitor-Induced Myocarditis , Journal of Analytical Oncology: Vol. 9 (2020)
- Arturo Novoa Vargas, Karla Sánchez Bautista, Ismael Coudillo Luna, Lipoidic Cells Ovary Cancer, Clinic Case and Literature Review , Journal of Analytical Oncology: Vol. 3 No. 1 (2014)
- Martin Czejka, Andreas Kiss, Eva Ostermann, Johannes Schueller, Mansoor Ahmed, Najia Mansoor, Tasneem Ahmad, Metabolic Activation and Inactivation of Irinotecan when Combined with the Human Monoclonal Antibody Bevacizumab , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
- Martin Czejka, Ernst Ulsperger, Heinz Schnait, Tamara Brumnik, Joerg Schierholz, Philipp Buchner, Richard Greil , Evidence for the Conversion of Docetaxel into 7-Epidocetaxel in Patients Receiving Conventional Taxotere® Based Chemotherapy , Journal of Analytical Oncology: Vol. 3 No. 2 (2014)
- Hasibe Cingilli Vural, Sadettin Ünsal, Gizem Tosunal, A Real-Time Quantitative PCR Assay for Quantification of c-Myc DNA in Patients who Suffers from Leukemia , Journal of Analytical Oncology: Vol. 2 No. 1 (2013)
- Maria Caffo, Maria Angela Pino, Gerardo Caruso, Francesco Tomasello, Antisense Molecular Therapy in Cerebral Gliomas , Journal of Analytical Oncology: Vol. 1 No. 2 (2012)
- Dominique Vanessa Sob Djuendje, Armel Herve Nwabo Kamdje, Blaise Nkegoum, Prevalence of Precancerous Lesions among Positive HIV Women in the Hospital Complex and University of Yaounde (Cameroun) , Journal of Analytical Oncology: Vol. 6 No. 2 (2017)
- David Wetherell, Kiran Manya, Nathan Papa, Danny Chui, Nathan Lawrentschuk, Saving Nephrons: Current Surgical Options in Partial Nephrectomy , Journal of Analytical Oncology: Vol. 1 No. 1 (2012)
You may also start an advanced similarity search for this article.
